Skip to content

Enhancing Attention and Wellbeing Using Digital Therapeutics

Optimizing a Closed-loop Digital Meditation Intervention for Remediating Cognitive Decline and Reducing Stress in Older Adults

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06397469
Enrollment
4000
Registered
2024-05-03
Start date
2024-04-01
Completion date
2029-06-01
Last updated
2026-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, MCI, Cognitive Decline

Keywords

healthy aging, attention, cognition, dementia, intervention, digital, behavioral, prevention, decline, stress reduction, Quality of life

Brief summary

The goals of the proposed research are to first determine the minimal and/or optimal dose of a digital intervention required for cognitive enhancement, and then to examine the impact of several potential moderators of treatment effects (i.e., cognitive decline, AD polygenic hazard score, cardiovascular risk, and race/ethnicity). This knowledge gained from his high-impact study with transform the field of cognitive interventions, paving the way for a precision medicine model for cognitive enhancing interventions that improve quality of life for older adults and individuals with cognitive deficits at risk of developing dementia.

Interventions

DEVICEMediTrain

MediTrain is a tablet-based, meditation-inspired, cognitive training game aimed at improving self-regulation of internal attention and distractions. It was developed in collaboration with meditation thought-leader Jack Kornfield, and Zynga, a world-class video game company. It was created to make benefits of concentrative meditation more easily accessible to anyone, including complete novices. This is achieved by creating a game that yields quantifiable and attainable goals, provides feedback, and includes an adaptive algorithm to gradually increase difficulty as users improve.

DEVICEWorder

Worder was designed to enhance visual motor and visual spatial skills in individuals of all ages and cognitive abilities. Visual processing is required for all cognitive abilities that involve vision including attention, working memory, and task management. Worder's goal is to improve cognitive function more broadly by developing this critical skill underlying multiple abilities.

Sponsors

University of California, San Francisco
Lead SponsorOTHER
National Institute on Aging (NIA)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

double blind

Eligibility

Sex/Gender
ALL
Age
60 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* 60+ years old (adult) * English language fluency * owning a smartphone or tablet

Exclusion criteria

* Under 60 years old (minor)

Design outcomes

Primary

MeasureTime frameDescription
Change on the Mobile Continuous Performance Task (CPT) over timebaseline, immediate follow-up, and at a 6 month follow-upThe CPT is a 23-minute task, where participants are instructed to respond to target stimuli (squares at the top of the screen) and withhold responses to non-target stimuli (squares at the bottom of the screen). Performance will be quantified as: (1) mean reaction times, (2) standard deviation of reaction times (RTV), and (3) d-prime (comparing correct target detections or 'hits' to incorrect non-target detections or 'false alarms').

Secondary

MeasureTime frameDescription
Change on the Adaptive Cognitive Evaluation (ACE) over timebaseline, immediate follow-up, and at a 6 month follow-upThe ACE is a mobile cognitive assessment tool, which includes a battery of cognitive control tests for rapid tests of cognition. The sub-tests (or 'modules') in ACE are adapted from standardized tasks to rapidly assess various aspects of cognition, including attention, memory, and multitasking. We will assess response time, accuracy, and response time variability in each case, with faster/more accurate/less variable performance being indicative of improved cognitive control.

Countries

United States

Contacts

CONTACTDavid Ziegler, PhD
david.ziegler@ucsf.edu4154762164
CONTACTMonique de Villa, MS, MPH
meditrain@ucsf.edu209-233-3878
PRINCIPAL_INVESTIGATORAdam Gazzaley, MD/PhD

University of California, San Francisco

PRINCIPAL_INVESTIGATORDavid Ziegler, PhD

University of California, San Francisco

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026